-
Notable Analyst Rating Changes 12/13: (CIEN) (ATHN) (AMZN) Upgraded; (BP) (APC) (LULU) Downgraded
-
Cooperman's Omega Goes Back Small Into Apple (AAPL), Enters Ceasers (CZR), Liquidates Facebook (FB) (more...)
-
Cooperman's Omega Advisors Gets Into Gold and Silver ETFs (GLD) (GDX) (SLV) (more...)
-
Pre-Open Movers 10/09: (SPB) (RSH) (QCOR) Higher; (EW) (OC) (NFLX) Lower (more...)
-
After-Hours Movers 10/08: (EW) (ANGO) (COV) Lower (more...)
-
Paulson & Co. Trims Some Gold (GLD) and Exits Banks in a Big Way (BAC) (C) (WFC)
-
Barclays 2012 Top Picks: Becoming Somewhat More Optimistic - Signs of Progress, Growth and Soft Landings
-
Paulson's Paulson & Co. Releases Q3 2011 13F
-
Notable Analyst Rating Changes 09/09: (DB) (SUN) (TWX) Upgraded; (RIMM) (REGN) (SNY) Downgraded
-
Citi Starts Covidien Ltd (COV) at Buy
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Notable Analyst Rating Changes 03/31: (TSLA) (ARMH) (EMR) Upgraded; (OPEN) (CBE) (BMY) Downgraded
-
Tepper's Appaloosa Boosts Bank Bets, Goes For Beaten-Up Tech (C) (MSFT) (WFC) (HPQ) (AMAT)
-
Notable Analyst Rating Changes 12/14: ABC, CMCSA, COV, AMGN Upgraded; MFN, TSO, VECO, CAKE Downgraded
-
Notable Analyst Rating Changes 09/10: MCO, NOK, CCE, ALL Upgraded; DELL, CSCO, ADBE, SFD Downgraded
-
Notable 52-Week High's and Low's of the Day 07/29: CTXS, ENTR, CROX, VMED High; NVDA, SYMC, LSI, COV Low
-
Citi Maintains a 'Hold' on Hospira (HSP); Stuck Between Stations; COV Remains 'Top Pick'
-
Citi Maintains a 'Buy' on Zimmer Holdings (ZMH); 2Q10: COV is our Top Pick
-
Citi Maintains a 'Hold' on Abbott Laboratories (ABT); Q2: Diversity Works
-
Citi Maintains a 'Hold' on Somanetics Corp (SMTS); Walk Off – Inline Results Ahead of COV Acquisition
-
Morning Movers 6/1: EVVV, MCCC, PANL, HEV, PUK Higher; APC, WMG, BP, BEAT, DRQ, ATPG Lower
-
Citi Maintains a 'Buy' on Baxter International (BAX), Removes From 'Top Picks Live' List
-
Citi Maintains a 'Buy' on Covidien (COV), Adds to 'Top Picks Live' List
-
David Moenning's Daily State of the Markets: 4/30
-
Citi Maintains a 'Buy' on Covidien (COV); Valuation Very Attractive
-
Citi Maintains 'Buy' on Covidien Ltd (COV), Lowers Price Target
-
David Moenning's Daily State of the Markets: 11/17
-
Loeb's Third Point 13F; Shows New Stakes in BUD, C, CVS, MER, WEN, UST, Sells Out of MA
-
Citi Maintains a 'Buy' Rating on Medical Technology Stocks, But Lowers Price Targets
-
David Moenning's Daily State of the Markets: 10/10
-
Citi Introduces Investment Research's TEN+ (Ten Exceptional Names Plus) List for 2008-09

